Skip to content
Trial Eligibility
Menu

Inflammatory Challenge and Fear

NCT06630884

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to learn if short-term changes in the immune system alter how we process information and experience fear. The main questions it aims to answer are: Do people who receive typhoid vaccine respond differently than those who receive a placebo saline vaccine? Do people who receive typhoid vaccine experience changes in how they think and feel?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Posttraumatic Stress Disorder (PTSD)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Francisco
Last updated on ClinicalTrials.gov
September 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • San Francisco VA Health Care System · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.